Skip to main content
Clinical Trials/NCT04500210
NCT04500210
Completed
Phase 3

A Double-blind, Randomized, Parallel Group, Phase III Comparative Study of Turmeric Extract and Placebo to Patients With Mild to Moderate Arthrosis of the Knee and or Hip.

Kaj Winther Hansen1 site in 1 country120 target enrollmentJanuary 1, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Arthralgia
Sponsor
Kaj Winther Hansen
Enrollment
120
Locations
1
Primary Endpoint
ADL (Activity of daily living)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aim of this study is to test if an extract of Turmeric can alleviate symptoms of osteoarthritis in volunteers with osteoarthritis of the hip and or knee.

Detailed Description

The included volunteers, who are devided into two groups either placebo or turmeric extract, will be tested using WOMAC questionnaires focussing on pain, stiffness and daily activity. In addition different aspects of quality of life will be evaluated and the consumption of rescue medication will be recorded in patients personal diary. The treatment period is 3 month with the posibility to continue for an additional 3 month.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
September 7, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kaj Winther Hansen
Responsible Party
Sponsor Investigator
Principal Investigator

Kaj Winther Hansen

professor, MD, DMsCi

University of Copenhagen

Eligibility Criteria

Inclusion Criteria

  • Healthy Volunteers
  • 40 years of age or more
  • Osteoarthritis of the hip and or the knee
  • Suffering from pain in the hip and or knee -

Exclusion Criteria

  • If volunteers are on a waiting list for hip or knee surgery
  • If the volunteers are involved in an other clinical trial
  • If the volunteers are taking other herbal remedies, which canhav influende on # Osteoarthritis.
  • Abusers of alcohol and drugs
  • Volunteers not easy to cope with

Outcomes

Primary Outcomes

ADL (Activity of daily living)

Time Frame: 6 month

Difference in WOMAC ADL on a 100 mm VAS scale (high levels worse)

Pain

Time Frame: 6 month

Difference in WOMAC pain on a 100 mm VAS scale (high levels worse)

Rescue medication

Time Frame: 6 month

Consumption of rescue medication from diaries (mg)

Secondary Outcomes

  • Stiffness of joints(6 month)
  • The volunteer evaluation of Global Disease Severity (PGAD)(6 month)

Study Sites (1)

Loading locations...

Similar Trials